Your browser doesn't support javascript.
loading
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Jamieson, D; Tung, A T Y; Knox, R J; Boddy, A V.
Affiliation
  • Jamieson D; Northern Institute for Cancer Research, University of Newcastle upon Tyne, Paul O'Gorman Building, Medical School, Newcastle upon Tyne NE2 4HH, UK. david.jamieson@newcastle.ac.uk
Br J Cancer ; 95(9): 1229-33, 2006 Nov 06.
Article in En | MEDLINE | ID: mdl-17031400
ABSTRACT
NRHQuinone Oxidoreductase 2 (NQO2) has been described as having no enzymatic activity with nicotinamide adenine dinucleotide (NADH) or NADPH as electron donating cosubstrates. Mitomycin C (MMC) is both a substrate for and a mechanistic inhibitor of the NQO2 homologue NQO1. NRHquinone oxidoreductase 2 catalysed the reduction of MMC at pH 5.8 with NADH as a co-factor. This reaction results in species that inhibit the NQO2-mediated metabolism of CB1954. In addition, MMC caused an increase in DNA cross-links in a cell line transfected to overexpress NQO2 to an extent comparable to that observed with an isogenic NQO1-expressing cell line. These data indicate that NQO2 may contribute to the metabolism of MMC to cytotoxic species.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinone Reductases / Mitomycin / NAD Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2006 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinone Reductases / Mitomycin / NAD Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2006 Document type: Article Affiliation country: